Gaucher’s Disease, Myoclonic Seizures after Splenectomy: A Case Report
Journal Title: Neuro – Open Journal - Year 2015, Vol 2, Issue 2
Abstract
Gaucher’s Disease (GD) is the most prevalent lysosomal storage disorder, resulting from the accumulation of glucocerebrosidase in the cells of macrophagemonocyte system due to a deficiency in lysosomal glucocerebrosidase. Here we report a case of GD, a patient that presented with myoclonic seizures after splenectomy, was just diagnosed as myoclonic seizures at first attending a neurologist. GD is so rare that it is easily missed diagnosis or misdiagnosis in the clinic. When neurologists engage a patient presented with myoclonic seizures, it is importance to collect more information about his medical and family history, have him done essential examinations, especially of children with unexplained splenomegaly.
Authors and Affiliations
Fu-Hua Peng
Keywords
Related Articles
- EP ID EP553058
- DOI 10.17140/ NOJ-2-113
- Views 117
- Downloads 0
Drugs Against Calcitonin Gene-Related Peptide and its Receptor Used in the Treatment of Migraine: What are the New Progresses?
Migraine is a chronic headache disorder that its exact pathomechanism is not very well known but research in the last two decades indicates that it might be a brain disorder, a dismodulation of sensory processing of the...
Pulvinar Complex: Relay Center or Something More?
The pulvinar is a collection of thalamic nuclei which is often considered mainly with visual processing and attention. The unique thing about this thalamic brain area is that, in phylogeny, this area is considered to be...
Mobile Stroke Unit (MSU): The Future of Acute Stroke Treatment?
Time is the key factor in brain survivability in acute stroke treatment.1The therapeutic effects of intravenous recombinant tissue Plasminogen Activator (IV rtPA) are highly dependent on time.1-3 Stroke patients presenti...
Endovascular treatment of Stroke: Historical Perspective
Effective acute ischemic stroke therapy hinges on rapid restoration of blood flow to the ischemic tissue. Since the National Institute of Neurological Diseases and Stroke r-tPA study,1 intravenous fibrinolytic therapy in...
Neuromodulation in the Treatment of Migraine: Progress in Nerve Stimulation
Migraine is a type of primary headache disorder that can become chronic and disabling. The exact pathomechanism of migraine is not known very well and its treatment is also difficult in some cases. There are several medi...